GPT and metabolic dysfunction-associated steatotic liver disease: Both the studies reported no difference in the levels of alanine transaminase (ALT) and aspartate aminotransferase (AST), the lipid profiles, or expression of genes related to NAFLD between the resveratrol and the placebo groups [215,216].